Initial Testing of VNP40101M (Cloretazine(®)) by the Pediatric Preclinical Testing Program

Por Keir, Stephen T., Morton, Christopher L., Billups, Catherine, Smith, Malcolm A., Houghton, Peter J., Gururangan, Sridharan
Publicado em 2008

The IGF-1 Receptor Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma

Por Kurmasheva, Raushan T., Dudkin, Lorina, Billups, Catherine, Debelenko, Larisa V., Morton, Christopher L., Houghton, Peter J.
Publicado em 2009

Initial Testing of the Multitargeted Kinase Inhibitor Pazopanib by the Pediatric Preclinical Testing Program

Por Keir, Stephen T., Morton, Christopher L., Wu, Jianrong, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
Publicado no Pediatr Blood Cancer (2011)

National Cancer Institute Pediatric Preclinical Testing Program: Model Description for In Vitro Cytotoxicity Testing

Por Kang, Min H., Smith, Malcolm A., Morton, Christopher L., Keshelava, Nino, Houghton, Peter J., Reynolds, C. Patrick
Publicado em 2010

Inhibition of Type I Interferon-Mediated Antiviral Action in Human Glioma Cells by the IKK Inhibitors BMS-345541 and TPCA-1

Por Du, Ziyun, Whitt, Michael A., Baumann, Jessica, Garner, Jo Meagan, Morton, Christopher L., Davidoff, Andrew M., Pfeffer, Lawrence M.
Publicado em 2012

Multisite Promiscuity in the Processing of Endogenous Substrates by Human Carboxylesterase 1

Por Bencharit, Sompop, Edwards, Carol C., Morton, Christopher L., Howard-Williams, Escher L., Kuhn, Peter, Potter, Philip M., Redinbo, Matthew R.
Publicado em 2006

Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector

Por Piras, Bryan A, Drury, Jason E, Morton, Christopher L, Spence, Yunyu, Lockey, Timothy D, Nathwani, Amit C, Davidoff, Andrew M, Meagher, Michael M
Publicado no Mol Ther Methods Clin Dev (2016)

Combination Testing (Stage 2) of the anti-IGF-1 Receptor Antibody IMC-A12 with Rapamycin by the Pediatric Preclinical Testing Program

Por Kolb, E. Anders, Gorlick, Richard, Maris, John M., Keir, Stephen T., Morton, Christopher L., Wu, Jianrong, Wozniak, Amy W., Smith, Malcolm A., Houghton, Peter J.
Publicado em 2011

Combination Testing of Cediranib (AZD2171) against Childhood Cancer Models by the Pediatric Preclinical Testing Program

Por Morton, Christopher L., Maris, John M., Keir, Stephen T., Gorlick, Richard, Kolb, E. Anders, Billups, Catherine A., Wu, Jianrong, Smith, Malcolm A., Houghton, Peter J.
Publicado em 2011

Evaluation of Cytarabine Against Ewing Sarcoma Xenografts by the Pediatric Preclinical Testing Program

Por Houghton, Peter J., Morton, Christopher L., Kang, Min, Reynolds, C. Patrick, Billups, Catherine A., Favours, Edward, Payne-Turner, Debbie, Tucker, Chandra, Smith, Malcolm A.
Publicado no Pediatr Blood Cancer (2010)

Retraction notice to “Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-κB inhibition” [j.surg 151 (2012) 736–744]

Por Orr, Wayne S., Denbo, Jason W., Saab, Karim R., Myers, Adrianne L., Ng, Catherine Y., Zhou, Junfang, Morton, Christopher L., Pfeffer, Lawrence M., Davidoff, Andrew M.
Publicado no Surgery (2016)

Liposome-Encapsulated Curcumin Suppresses Neuroblastoma Growth Through Nuclear Factor-κB Inhibition

Por Orr, W. Shannon, Denbo, Jason W., Saab, Karim R., Myers, Adrianne L., Ng, Catherine Y., Zhou, Junfang, Morton, Christopher L., Pfeffer, Lawrence M., Davidoff, Andrew M.
Publicado em 2012

Initial Testing of a Monoclonal Antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program

Por Houghton, Peter J., Morton, Christopher L., Gorlick, Richard, Kolb, E. Anders, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Wu, Jianrong, Smith, Malcolm A.
Publicado em 2010

Initial Testing of the Replication Competent Seneca Valley Virus (NTX-010) by the Pediatric Preclinical Testing Program

Por Morton, Christopher L., Houghton, Peter J., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Kang, Min H., Maris, John M., Keir, Stephen T., Wu, Jianrong, Smith, Malcolm A.
Publicado em 2010

Initial Testing (Stage 1) of the Kinesin Spindle Protein Inhibitor Ispinesib by the Pediatric Preclinical Testing Program

Por Carol, Hernan, Lock, Richard, Houghton, Peter J., Morton, Christopher L., Kolb, E. Anders, Gorlick, Richard, Reynolds, C. Patrick, Maris, John M., Keir, Stephen T., Billups, Catherine A., Smith, Malcolm A.
Publicado em 2009

Initial Testing (Stage 1) of the Polyamine Analog PG11047 by the Pediatric Preclinical Testing Program

Por Smith, Malcolm A., Maris, John M., Lock, Richard, Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Carol, Hernan, Morton, Christopher L., Reynolds, C. Patrick, Kang, Min H., Houghton, Peter J.
Publicado em 2011

Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity

Por Orr, W. Shannon, Denbo, Jason W., Saab, Karim R., Ng, Catherine Y., Wu, Jianrong, Li, Kui, Garner, Jo Meagan, Morton, Christopher L., Du, Ziyun, Pfeffer, Lawrence M., Davidoff, Andrew M.
Publicado em 2013

Initial Testing of Aplidin by the Pediatric Preclinical Testing Program

Por Morton, Christopher L., Houghton, Peter J., Gorlick, Richard, Kolb, E. Anders, Lock, Richard, Carol, Hernan, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Maris, John M., Billups, Catherine, Smith, Malcolm A.
Publicado em 2009

Initial Testing (Stage 1) of Vorinostat (SAHA) by the Pediatric Preclinical Testing Program

Por Keshelava, Nino, Houghton, Peter J., Morton, Christopher L., Lock, Richard B., Carol, Hernan, Keir, Stephen T., Maris, John M., Reynolds, C Patrick, Gorlick, Richard, Kolb, E. Anders, Wu, Jianrong, Smith, Malcolm A.
Publicado em 2009

Initial Testing of the Aurora Kinase A Inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)

Por Maris, John M., Morton, Christopher L., Gorlick, Richard, Kolb, E. Anders, Lock, Richard, Carol, Hernan, Keir, Stephen T., Reynolds, C. Patrick, Kang, Min H., Wu, Jianrong, Smith, Malcolm A., Houghton, Peter J.
Publicado em 2010